tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market
PCRX
Pacira Pharmaceuticals
RESEARCH TOOLSreports
Want to see PCRX full AI Analyst Report?

Pacira Pharmaceuticals (PCRX) Income Statement

384 Followers

Pacira Pharmaceuticals Income Statement

Last quarter (Q1 2026), Pacira Pharmaceuticals's total revenue was $177.38M, an increase of 5.00% from the same quarter last year. In Q1, Pacira Pharmaceuticals's net income was $7.08M. See Pacira Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 726.41M$ 700.97M$ 674.98M$ 666.82M$ 541.53M
Gross Profit
$ 519.37M$ 530.54M$ 490.31M$ 467.53M$ 401.28M
Operating Expenses
$ 491.27M$ 603.91M$ 402.63M$ 407.50M$ 311.35M
Depreciation and Amortization
$ 91.02M$ 78.78M$ 75.57M$ 91.50M$ 28.55M
EBITDA
$ 119.13M$ 29.12M$ 154.59M$ 140.38M$ 113.95M
Operating Income
$ 28.10M$ -73.37M$ 87.67M$ 60.02M$ 89.92M
Other Income/Expenses
$ -11.23M$ 10.27M$ -25.97M$ -46.72M$ -33.52M
Pretax Income
$ 16.87M$ -63.11M$ 61.70M$ 13.30M$ 56.40M
Net Income
$ 7.03M$ -99.56M$ 41.95M$ 15.91M$ 41.98M
Per Share Metrics
Basic EPS
$ 0.16$ -2.15$ 0.91$ 0.35$ 0.95
Diluted EPS
$ 0.16$ -2.15$ 0.89$ 0.34$ 0.92
Weighted Average Shares Outstanding
 44.57M 46.24M 46.22M 45.52M 44.26M
Weighted Average Shares Outstanding (Diluted)
 45.04M 46.24M 51.98M 46.54M 45.63M
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History